D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
Bunge Global
BG
$23.6B
| $265K | ﹤0.01% |
+5,000
| New | +$265K |
|
|
AUD
3227
PUT
DELISTED
Audacy, Inc.
AUD
| $263K | ﹤0.01% |
50,000
| – | – |
|
|
VNE
3228
PUT
DELISTED
Veoneer, Inc.
VNE
| $263K | ﹤0.01% |
+11,500
| New | +$319K |
|
|
WUBA
3229
CALL
DELISTED
58.com Inc
WUBA
| $263K | ﹤0.01% |
4,000
-10,000
| -71% | -$630K |
|
3230
Stepan Co
SCL
$1.31B
| $262K | ﹤0.01% |
2,993
-188
| -6% | -$16.3K |
|
|
SRC
3231
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $262K | ﹤0.01% |
6,583
-8,155
| -55% | -$311K |
|
|
BLD
3232
DELISTED
TopBuild
BLD
| $261K | ﹤0.01% |
4,029
-90,112
| -96% | -$5.07M |
|
3233
Salesforce
CRM
$134B
| $261K | ﹤0.01% |
1,650
-19,557
| -92% | -$3.03M |
|
|
SRDX
3234
CALL
DELISTED
Surmodics
SRDX
| $261K | ﹤0.01% |
6,000
-10,300
| -63% | -$525K |
|
3235
PUT
Sun Communities
SUI
$15B
| $261K | ﹤0.01% |
+2,200
| New | +$245K |
|
|
MLNX
3236
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $260K | ﹤0.01% |
+2,200
| New | +$221K |
|
3237
Kadant
KAI
$3.69B
| $259K | ﹤0.01% |
2,947
-300
| -9% | -$25.8K |
|
3238
RenaissanceRe
RNR
$13.7B
| $258K | ﹤0.01% |
1,800
| – | – |
|
3239
PUT
Dycom Industries
DY
$12.9B
| $257K | ﹤0.01% |
+5,600
| New | +$307K |
|
3240
Future Fuel
FF
$204M
| $256K | ﹤0.01% |
19,098
-24,023
| -56% | -$408K |
|
|
SBNY
3241
CALL
DELISTED
Signature Bank
SBNY
| $256K | ﹤0.01% |
2,000
-18,000
| -90% | -$2.29M |
|
3242
CALL
Ryanair
RYAAY
$29.5B
| $255K | ﹤0.01% |
+8,500
| New | +$246K |
|
3243
LeMaitre Vascular
LMAT
$2.18B
| $254K | ﹤0.01% |
+8,207
| New | +$219K |
|
3244
LendingTree
TREE
$544M
| $254K | ﹤0.01% |
722
-31,617
| -98% | -$9.54M |
|
3245
Barnes & Noble Education
BNED
$412M
| $253K | ﹤0.01% |
603
+290
| +93% | +$157K |
|
3246
CALL
Oil States International
OIS
$522M
| $253K | ﹤0.01% |
+14,900
| New | +$252K |
|
|
LN
3247
DELISTED
LINE Corporation
LN
| $253K | ﹤0.01% |
7,190
-525
| -7% | -$18.9K |
|
3248
Harmony Gold Mining
HMY
$9.92B
| $252K | ﹤0.01% |
132,500
-450,795
| -77% | -$884K |
|
3249
MeiraGTx Holdings
MGTX
$1.09B
| $252K | ﹤0.01% |
+14,606
| New | +$206K |
|
|
SKX
3250
PUT
DELISTED
Skechers
SKX
| $252K | ﹤0.01% |
+7,500
| New | +$224K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.